Anti-scarring effects of butaprost on human subconjunctival Tenon’s fibroblasts
AIM: To investigate the toxicity of the E-prostanoid 2 (EP2) receptor agonist, butaprost against human subconjunctival (Tenon’s capsule) fibroblasts, and to determine the underlying mechanism. METHODS: We isolated Tenon’s fibroblasts from the subconjunctival area of healthy subjects and evaluated t...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2017-07-01
|
| Series: | International Journal of Ophthalmology |
| Subjects: | |
| Online Access: | http://www.ijo.cn/en_publish/2017/7/20170702.pdf |
| _version_ | 1828745319001620480 |
|---|---|
| author | Jong Hoon Shin Je Hyun Seo Jae Ho Jung Tae Woo Kim |
| author_facet | Jong Hoon Shin Je Hyun Seo Jae Ho Jung Tae Woo Kim |
| author_sort | Jong Hoon Shin |
| collection | DOAJ |
| description | AIM: To investigate the toxicity of the E-prostanoid 2 (EP2) receptor agonist, butaprost against human subconjunctival (Tenon’s capsule) fibroblasts, and to determine the underlying mechanism.
METHODS: We isolated Tenon’s fibroblasts from the subconjunctival area of healthy subjects and evaluated the types of EP receptors expressed using quantitative real-time reverse transcription polymerase chain reaction (RT-PCR). The toxicity of butaprost against the fibroblasts was evaluated using methyl thiazolyl tetrazolium and lactic dehydrogenase assays. The inhibition of conjunctival fibroblast proliferation by butaprost was assessed by measuring α-actin levels. The underlying mechanism was assessed by measuring intracellular cyclic adenosine monophosphate (cAMP) levels. Intergroup differences were statistically analyzed using an independent t-test. Densitometry of the Western blot bands was performed using the Image J software.
RESULTS: Quantitative real-time RT-PCR revealed that the fibroblast EP2 receptor levels were higher than those of the other EP receptors. Butaprost did not show toxicity against Tenon’s tissue, but inhibited conjunctival fibroblast proliferation by reducing collagen synthesis. EP2 receptor activation enhanced the cAMP cascade, which might be an important mechanism underlying this effect.
CONCLUSION: Butaprost effectively reduces the subconjunctival scarring response. Given the significance of wound healing modulation in blebs, butaprost’s inhibitory effect on subconjunctival Tenon’s fibroblasts may be beneficial in managing postoperative scarring in glaucoma surgery. |
| first_indexed | 2024-04-14T03:59:48Z |
| format | Article |
| id | doaj.art-f522c9ff3eef462e94a2f2c776d2a375 |
| institution | Directory Open Access Journal |
| issn | 2222-3959 2227-4898 |
| language | English |
| last_indexed | 2024-04-14T03:59:48Z |
| publishDate | 2017-07-01 |
| publisher | Press of International Journal of Ophthalmology (IJO PRESS) |
| record_format | Article |
| series | International Journal of Ophthalmology |
| spelling | doaj.art-f522c9ff3eef462e94a2f2c776d2a3752022-12-22T02:13:38ZengPress of International Journal of Ophthalmology (IJO PRESS)International Journal of Ophthalmology2222-39592227-48982017-07-011071028103310.18240/ijo.2017.07.02Anti-scarring effects of butaprost on human subconjunctival Tenon’s fibroblastsJong Hoon Shin0Je Hyun Seo1Jae Ho Jung2Tae Woo Kim3Department of Ophthalmology, Pusan National University Hospital, Busan 49241, KoreaDepartment of Ophthalmology, Pusan National University Yangsan Hospital, Yangsan 50612, Korea; Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, KoreaDepartment of Ophthalmology, Pusan National University Yangsan Hospital, Yangsan 50612, Korea; Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, KoreaDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam 13620, KoreaAIM: To investigate the toxicity of the E-prostanoid 2 (EP2) receptor agonist, butaprost against human subconjunctival (Tenon’s capsule) fibroblasts, and to determine the underlying mechanism. METHODS: We isolated Tenon’s fibroblasts from the subconjunctival area of healthy subjects and evaluated the types of EP receptors expressed using quantitative real-time reverse transcription polymerase chain reaction (RT-PCR). The toxicity of butaprost against the fibroblasts was evaluated using methyl thiazolyl tetrazolium and lactic dehydrogenase assays. The inhibition of conjunctival fibroblast proliferation by butaprost was assessed by measuring α-actin levels. The underlying mechanism was assessed by measuring intracellular cyclic adenosine monophosphate (cAMP) levels. Intergroup differences were statistically analyzed using an independent t-test. Densitometry of the Western blot bands was performed using the Image J software. RESULTS: Quantitative real-time RT-PCR revealed that the fibroblast EP2 receptor levels were higher than those of the other EP receptors. Butaprost did not show toxicity against Tenon’s tissue, but inhibited conjunctival fibroblast proliferation by reducing collagen synthesis. EP2 receptor activation enhanced the cAMP cascade, which might be an important mechanism underlying this effect. CONCLUSION: Butaprost effectively reduces the subconjunctival scarring response. Given the significance of wound healing modulation in blebs, butaprost’s inhibitory effect on subconjunctival Tenon’s fibroblasts may be beneficial in managing postoperative scarring in glaucoma surgery.http://www.ijo.cn/en_publish/2017/7/20170702.pdf1033butaprostTenon’s capsuletrabeculectomyfibroblasts |
| spellingShingle | Jong Hoon Shin Je Hyun Seo Jae Ho Jung Tae Woo Kim Anti-scarring effects of butaprost on human subconjunctival Tenon’s fibroblasts International Journal of Ophthalmology 1033 butaprost Tenon’s capsule trabeculectomy fibroblasts |
| title | Anti-scarring effects of butaprost on human subconjunctival Tenon’s fibroblasts |
| title_full | Anti-scarring effects of butaprost on human subconjunctival Tenon’s fibroblasts |
| title_fullStr | Anti-scarring effects of butaprost on human subconjunctival Tenon’s fibroblasts |
| title_full_unstemmed | Anti-scarring effects of butaprost on human subconjunctival Tenon’s fibroblasts |
| title_short | Anti-scarring effects of butaprost on human subconjunctival Tenon’s fibroblasts |
| title_sort | anti scarring effects of butaprost on human subconjunctival tenon s fibroblasts |
| topic | 1033 butaprost Tenon’s capsule trabeculectomy fibroblasts |
| url | http://www.ijo.cn/en_publish/2017/7/20170702.pdf |
| work_keys_str_mv | AT jonghoonshin antiscarringeffectsofbutaprostonhumansubconjunctivaltenonsfibroblasts AT jehyunseo antiscarringeffectsofbutaprostonhumansubconjunctivaltenonsfibroblasts AT jaehojung antiscarringeffectsofbutaprostonhumansubconjunctivaltenonsfibroblasts AT taewookim antiscarringeffectsofbutaprostonhumansubconjunctivaltenonsfibroblasts |